Screening for colorectal neoplasia with faecal tests

被引:9
作者
Fraser, Callum G. [1 ]
机构
[1] Univ Dundee, Ctr Res Canc Prevent & Screening, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
关键词
D O I
10.1016/S1470-2045(11)70106-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:516 / 517
页数:2
相关论文
共 5 条
[1]   Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests [J].
Brenner, Hermann ;
Haug, Ulrike ;
Hundt, Sabrina .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) :1643-1649
[2]   Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort [J].
Chen, Li-Sheng ;
Yen, Amy Ming-Fang ;
Chiu, Sherry Yueh-Hsia ;
Liao, Chao-Sheng ;
Chen, Hsiu-Hsi .
LANCET ONCOLOGY, 2011, 12 (06) :551-558
[3]   Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal Cancers [J].
Droste, Jochim S. Terhaar Sive ;
Oort, Frank A. ;
van der Hulst, Rene W. M. ;
van Heukelem, Henk A. ;
Loffeld, Ruud J. L. F. ;
van Turenhout, Sietze T. ;
Ben Larbi, Ilhame ;
Kanis, Shannon L. ;
Neerincx, Maarten ;
Raekers, Mirre ;
Coupe, Veerle M. H. ;
Bouman, Anneke A. ;
Meijer, Gerrit A. ;
Mulder, Chris J. J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (02) :272-280
[4]  
Fraser CG, 2011, CLIN LAB NEWS, V37, P8
[5]  
Segnan N, 2010, European guidelines for quality assurance in colorectal cancer screening and diagnosis, VFirst, P1